These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34157199)

  • 1. Visuospatial dysfunction is associated with posterior distribution of white matter damage in non-demented cerebral amyloid angiopathy.
    Su Y; Fu J; Zhang Y; Xu J; Dong Q; Cheng X
    Eur J Neurol; 2021 Sep; 28(9):3113-3120. PubMed ID: 34157199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds.
    Ii Y; Ishikawa H; Matsuyama H; Shindo A; Matsuura K; Yoshimaru K; Satoh M; Taniguchi A; Matsuda K; Umino M; Maeda M; Tomimoto H
    J Alzheimers Dis; 2020; 78(4):1765-1774. PubMed ID: 33185609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.
    Valenti R; Charidimou A; Xiong L; Boulouis G; Fotiadis P; Ayres A; Riley G; Kuijf HJ; Reijmer YD; Pantoni L; Gurol ME; Davidsdottir S; Greenberg SM; Viswanathan A
    J Alzheimers Dis; 2017; 56(4):1223-1227. PubMed ID: 28222510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cortical microinfarcts and total small vessel disease burden in cerebral amyloid angiopathy on 3-Tesla magnetic resonance imaging.
    Ii Y; Ishikawa H; Shindo A; Matsuyama H; Matsuura K; Matsuda K; Yoshimaru K; Satoh M; Kogue R; Umino M; Maeda M; Tomimoto H
    Eur J Neurol; 2021 Mar; 28(3):794-799. PubMed ID: 33098163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
    Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
    J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
    Pasi M; Boulouis G; Fotiadis P; Auriel E; Charidimou A; Haley K; Ayres A; Schwab KM; Goldstein JN; Rosand J; Viswanathan A; Pantoni L; Greenberg SM; Gurol ME
    Neurology; 2017 Jun; 88(23):2162-2168. PubMed ID: 28476760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
    Charidimou A; Martinez-Ramirez S; Reijmer YD; Oliveira-Filho J; Lauer A; Roongpiboonsopit D; Frosch M; Vashkevich A; Ayres A; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    JAMA Neurol; 2016 Aug; 73(8):994-1001. PubMed ID: 27366898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.
    Boulouis G; Charidimou A; Jessel MJ; Xiong L; Roongpiboonsopit D; Fotiadis P; Pasi M; Ayres A; Merrill ME; Schwab KM; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    Neurology; 2017 Feb; 88(9):878-884. PubMed ID: 28130469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers.
    Boulouis G; Charidimou A; Pasi M; Roongpiboonsopit D; Xiong L; Auriel E; van Etten ES; Martinez-Ramirez S; Ayres A; Vashkevich A; Schwab KM; Rosand J; Goldstein JN; Gurol ME; Greenberg SM; Viswanathan A
    J Neurol Sci; 2017 Sep; 380():64-67. PubMed ID: 28870591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total small vessel disease burden and brain network efficiency in cerebral amyloid angiopathy.
    Valenti R; Reijmer YD; Charidimou A; Boulouis G; Martinez SR; Xiong L; Fotiadis P; Jessel M; Ayres A; Riley G; Pantoni L; Edip Gurol M; Greenberg SM; Viswanathan A
    J Neurol Sci; 2017 Nov; 382():10-12. PubMed ID: 29110998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy.
    Viswanathan A; Patel P; Rahman R; Nandigam RN; Kinnecom C; Bracoud L; Rosand J; Chabriat H; Greenberg SM; Smith EE
    Stroke; 2008 Jul; 39(7):1988-92. PubMed ID: 18436874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.
    Xiong L; Davidsdottir S; Reijmer YD; Shoamanesh A; Roongpiboonsopit D; Thanprasertsuk S; Martinez-Ramirez S; Charidimou A; Ayres AM; Fotiadis P; Gurol E; Blacker DL; Greenberg SM; Viswanathan A
    J Alzheimers Dis; 2016 Mar; 52(1):171-8. PubMed ID: 27060947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location.
    Schwarz G; Banerjee G; Hostettler IC; Ambler G; Seiffge DJ; Brookes TS; Wilson D; Cohen H; Yousry T; Salman RA; Lip GYH; Brown MM; Muir KW; Houlden H; Jäger R; Werring DJ; Staals J;
    J Neurol Sci; 2022 Mar; 434():120165. PubMed ID: 35121207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.
    Charidimou A; Boulouis G; Haley K; Auriel E; van Etten ES; Fotiadis P; Reijmer Y; Ayres A; Vashkevich A; Dipucchio ZY; Schwab KM; Martinez-Ramirez S; Rosand J; Viswanathan A; Greenberg SM; Gurol ME
    Neurology; 2016 Feb; 86(6):505-11. PubMed ID: 26747886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging markers of cerebral amyloid angiopathy and hypertensive arteriopathy differentiate Alzheimer disease subtypes synergistically.
    Chen TB; Lee WJ; Chen JP; Chang SY; Lin CF; Chen HC
    Alzheimers Res Ther; 2022 Sep; 14(1):141. PubMed ID: 36180874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    van Harten TW; Heijmans A; van Rooden S; Wermer MJH; van Osch MJP; Kuijf HJ; van Veluw SJ; Greenberg SM; van Buchem MA; van der Grond J; van Walderveen MAA
    J Alzheimers Dis; 2022; 90(1):381-388. PubMed ID: 36120778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.
    Reijmer YD; Fotiadis P; Martinez-Ramirez S; Salat DH; Schultz A; Shoamanesh A; Ayres AM; Vashkevich A; Rosas D; Schwab K; Leemans A; Biessels GJ; Rosand J; Johnson KA; Viswanathan A; Gurol ME; Greenberg SM
    Brain; 2015 Jan; 138(Pt 1):179-88. PubMed ID: 25367025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
    Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
    Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
    McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
    Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.